{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:55:35Z","timestamp":1790837735973,"version":"4.1.0"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The delineation of myositis-specific autoantibody (MSA) subgroups over the past two decades has reframed environmental research in idiopathic inflammatory myopathies (IIMs), making it plausible to examine discrete exposure-phenotype pairings within serologically defined subgroups. This review synthesises evidence on environmental, occupational, infectious, and pharmacological exposures, with attention to phenotypic specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Ultraviolet radiation shapes MSA-specific geographic distributions at the population level and associates with dermatomyositis onset at the individual level. Disease onset follows MSA-specific seasonal patterns, replicated across geographically independent cohorts. Smoking amplifies antisynthetase syndrome risk through a gene-environment interaction with HLA-DRB1*03:01, whilst protecting against anti-TIF1-\u03b3 autoantibodies. Gestational and early-life tobacco smoke exposure is consistently implicated as risks for juvenile IIM. Occupational silica exposure associates with antisynthetase syndrome and overlap myositis, with synergistic lung disease risk when combined with smoking. Statins, immune checkpoint inhibitors, anti-TNF\u03b1 agents, and interferons each induce immunopathologically distinct myositis phenotypes. Postpandemic surveillance has documented a rise in anti-MDA5 autoantibody-positive disease following SARS-CoV-2 infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Environmental exposures in IIM act preferentially in specific serological and genetic contexts, consistent with discrete exposure-phenotype pairings shaped by genetic background and age at exposure. Prospective, MSA-stratified studies with direct exposure quantification represent priority directions for the field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001184","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:00:10Z","timestamp":1788336010000},"page":"437-447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Environmental exposures and risks for the idiopathic inflammatory myopathies and its phenotypes: a narrative review"],"prefix":"10.1097","volume":"38","author":[{"given":"Taanya","family":"Talreja","sequence":"first","affiliation":[{"name":"Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust"},{"name":"Department of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham"},{"name":"Francis Crick Institute, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi","family":"Balse","sequence":"additional","affiliation":[{"name":"Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick W.","family":"Miller","sequence":"additional","affiliation":[{"name":"Environmental Autoimmunity Group, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"Rider","sequence":"additional","affiliation":[{"name":"Environmental Autoimmunity Group, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Schiffenbauer","sequence":"additional","affiliation":[{"name":"Environmental Autoimmunity Group, National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/acr.25423","article-title":"Environment, lifestyles, and climate change: the many nongenetic contributors to the long and winding road to autoimmune diseases","volume":"77","author":"Miller","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"1771091","DOI":"10.3389\/fimmu.2026.1771091","article-title":"Risk and protective factors in the natural history of autoimmunity","volume":"17","author":"Parks","year":"2026","journal-title":"Front Immunol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMra2415426","article-title":"Inflammatory myopathies","volume":"394","author":"Allenbach","year":"2026","journal-title":"N Engl J Med"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrrheum.2018.48","article-title":"Risk factors and disease mechanisms in myositis","volume":"14","author":"Miller","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11926-023-01120-x","article-title":"The role of environmental factors in the development of idiopathic inflammatory myopathies: A narrative review","volume":"25","author":"Yamamoto","year":"2023","journal-title":"Curr Rheumatol Rep"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/01.md.0000217525.82287.eb","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies","volume":"85","author":"O\u2019Hanlon","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"34976","DOI":"10.1074\/jbc.M805383200","article-title":"UV radiation regulates Mi-2 through protein translation and stability","volume":"283","author":"Burd","year":"2008","journal-title":"J Biol Chem"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1096-9896(199905)188:1<63::AID-PATH303>3.0.CO;2-E","article-title":"Keratinocyte apoptosis and p53 expression in cutaneous lupus and dermatomyositis","volume":"188","author":"Pablos","year":"1999","journal-title":"J Pathol"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome - much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2016.00097","article-title":"Silica, silicosis, and autoimmunity","volume":"7","author":"Pollard","year":"2016","journal-title":"Front Immunol"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1409497","DOI":"10.3389\/fmicb.2024.1409497","article-title":"Genetically predicted the causal relationship between gut microbiota and the risk of polymyositis\/dermatomyositis: a Mendelian randomization analysis","volume":"15","author":"Niu","year":"2024","journal-title":"Front Microbiol"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/art.11090","article-title":"Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease","volume":"48","author":"Okada","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/art.24702","article-title":"Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women","volume":"60","author":"Love","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-018-1617-9","article-title":"Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-\u03b3 autoantibodies in adult patients with myositis","volume":"20","author":"Parkes","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/acr.24059","article-title":"Association of ultraviolet radiation exposure with dermatomyositis in a national myositis patient registry","volume":"72","author":"Parks","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/rheumatology\/kex162","article-title":"Environmental factors associated with disease flare in juvenile and adult dermatomyositis","volume":"56","author":"Mamyrova","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/art.37985","article-title":"Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis","volume":"65","author":"Shah","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/acr.23840","article-title":"Association of short-term ultraviolet radiation exposure and disease severity in juvenile dermatomyositis: eesults from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry","volume":"71","author":"Neely","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.39466","article-title":"Brief report: association of myositis autoantibodies, clinical features, and environmental exposures at illness onset with disease course in juvenile myositis","volume":"68","author":"Habers","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/rheumatology\/keaa429","article-title":"Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America","volume":"60","author":"Mamyrova","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"e006636","DOI":"10.1136\/bmjopen-2014-006636","article-title":"Do solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?","volume":"5","author":"Wing","year":"2015","journal-title":"BMJ Open"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/art.1780341108","article-title":"Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and antisignal recognition particle autoantibodies","volume":"34","author":"Leff","year":"1991","journal-title":"Arthritis Rheum"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"e001214","DOI":"10.1136\/rmdopen-2020-001202","article-title":"Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease","volume":"6","author":"Nishina","year":"2020","journal-title":"RMD Open"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"106966","DOI":"10.1016\/j.imlet.2024.106966","article-title":"Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy: Seasonal patterns of myositis autoantibodies","volume":"272","author":"Palterer","year":"2025","journal-title":"Immunol Lett"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/art.21198","article-title":"Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups","volume":"52","author":"Sarkar","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"842586","DOI":"10.3389\/fmed.2022.842586","article-title":"The geospatial distribution of myositis and its phenotypes in the United States and associations with roadways: findings from a national myositis patient registry","volume":"9","author":"Hossain","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","article-title":"Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study","volume":"71","author":"Chinoy","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.semarthrit.2018.02.003","article-title":"The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis","volume":"48","author":"Schiffenbauer","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fmed.2019.00085","article-title":"Geospatial correlation of amyopathic dermatomyositis with fixed sources of airborne pollution: a retrospective cohort study","volume":"6","author":"Pearson","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/0961203312437806","article-title":"Atmospheric pollution: influence on hospital admissions in paediatric rheumatic diseases","volume":"21","author":"Vidotto","year":"2012","journal-title":"Lupus"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.envres.2015.12.021","article-title":"Fine particulate air pollution and systemic autoimmune rheumatic disease in two Canadian provinces","volume":"146","author":"Bernatsky","year":"2016","journal-title":"Environ Res"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.envres.2015.05.007","article-title":"Fine particulate air pollution, nitrogen dioxide, and systemic autoimmune rheumatic disease in Calgary, Alberta","volume":"140","author":"Bernatsky","year":"2015","journal-title":"Environ Res"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2013.08.005","article-title":"A review on the association between inflammatory myopathies and vaccination","volume":"13","author":"St\u00fcbgen","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12969-022-00684-9","article-title":"Environmental factors associated with juvenile idiopathic inflammatory myopathy clinical and serologic phenotypes","volume":"20","author":"Scalabrini","year":"2022","journal-title":"Pediatr Rheumatol"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"1539659","DOI":"10.3389\/fimmu.2025.1539659","article-title":"A possible role for immunogenetic factors in myositis developing after vaccination in the pre-COVID-19 era","volume":"16","author":"Alhassan","year":"2025","journal-title":"Front Immunol"},{"key":"R38-20261001","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/acr.25236","article-title":"Dermatomyositis in association with SARS-CoV-2 infection or COVID-19 vaccine","volume":"76","author":"Diaz-Menindez","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1136\/ard-2024-225869","article-title":"Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry","volume":"83","author":"Farisogullari","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R40-20261001","doi-asserted-by":"crossref","first-page":"keaf609","DOI":"10.1093\/rheumatology\/keaf609","article-title":"SARS-CoV-2 vaccination and myositis in Norway and Sweden","volume":"65","author":"Ljung","year":"2026","journal-title":"Rheumatology (Oxford)"},{"key":"R41-20261001","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM200003163421105","article-title":"Meta-analyses of the relation between silicone breast implants and the risk of connective-tissue diseases","volume":"342","author":"Janowsky","year":"2000","journal-title":"N Engl J Med"},{"key":"R42-20261001","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1002\/art.20587","article-title":"Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops","volume":"50","author":"O\u2019Hanlon","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R43-20261001","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00296-021-04851-1","article-title":"Association of various myositis-specific autoantibodies with dermatomyositis and polymyositis triggered by pregnancy","volume":"42","author":"Akiyama","year":"2022","journal-title":"Rheumatol Int"},{"key":"R44-20261001","doi-asserted-by":"crossref","first-page":"152880","DOI":"10.1016\/j.semarthrit.2025.152880","article-title":"In utero and early life exposures to smoking are associated with systemic autoimmune rheumatic diseases","volume":"75","author":"Ohnishi","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"R45-20261001","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/acr.22358","article-title":"Risk factors for juvenile dermatomyositis: exposure to tobacco and air pollutants during pregnancy","volume":"66","author":"Orione","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R46-20261001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s42358-024-00408-5","article-title":"The influence of environmental factors related to juvenile dermatomyositis (JDM), its course and refractoriness to treatment","volume":"64","author":"Val\u00f5es","year":"2024","journal-title":"Adv Rheumatol"},{"key":"R47-20261001","first-page":"194","article-title":"Comparison of pre and postnatal environmental exposures in United States versus Brazilian patients with juvenile dermatomyositis","volume":"44","author":"Arabi","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"R48-20261001","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.22751","article-title":"Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental exposures","volume":"56","author":"Vegosen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R49-20261001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2474-15-67","article-title":"Twins discordant for myositis and systemic lupus erythematosus show markedly enriched autoantibodies in the affected twin supporting environmental influences in pathogenesis","volume":"15","author":"Gan","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"R50-20261001","first-page":"21","article-title":"Stressful life events are associated with the diagnosis of systemic autoimmune rheumatic diseases among adults","volume":"43","author":"Ventura","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"R51-20261001","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/rheumatology\/keq277","article-title":"Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies","volume":"49","author":"Rider","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R52-20261001","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10067-013-2467-0","article-title":"Occupational exposure in patients with the antisynthetase syndrome","volume":"33","author":"Labirua-Iturburu","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R53-20261001","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/acr.25461","article-title":"Occupational and hobby exposures associated with myositis phenotypes in a national myositis patient registry","volume":"77","author":"Parks","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R54-20261001","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.amjmed.2015.05.001","article-title":"Prospective risk of rheumatologic disease associated with occupational exposure in a cohort of male construction workers","volume":"128","author":"Blanc","year":"2015","journal-title":"Am J Med"},{"key":"R55-20261001","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.39059","article-title":"Nested case-control study of selected systemic autoimmune diseases in World Trade Center rescue\/recovery workers","volume":"67","author":"Webber","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R56-20261001","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/acr2.11273","article-title":"Inorganic dust exposure during military service as a predictor of rheumatoid arthritis and other autoimmune conditions","volume":"3","author":"Ying","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"R57-20261001","doi-asserted-by":"crossref","first-page":"103468","DOI":"10.1016\/j.autrev.2023.103468","article-title":"Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues","volume":"22","author":"Khoo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R58-20261001","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen","year":"2016","journal-title":"N Engl J Med"},{"key":"R59-20261001","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multicenter study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R60-20261001","doi-asserted-by":"crossref","first-page":"e210031","DOI":"10.1212\/WNL.0000000000210031","article-title":"Immune checkpoint inhibitor myopathy: the double-edged sword of cancer immunotherapy","volume":"103","author":"Beecher","year":"2024","journal-title":"Neurology"},{"key":"R61-20261001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jamadermatol.2023.5418","article-title":"Causes and clinical presentation of drug-induced dermatomyositis: a systematic review","volume":"160","author":"Caravan","year":"2024","journal-title":"JAMA Dermatol"},{"key":"R62-20261001","doi-asserted-by":"crossref","first-page":"179180","DOI":"10.1155\/2014\/179180","article-title":"New onset of dermatomyositis\/polymyositis during anti-TNF-( therapies: a systematic literature review","volume":"2014","author":"Brunasso","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"R63-20261001","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00296-014-2984-4","article-title":"Dermatomyositis as a complication of interferon-( therapy: a case report and review of the literature","volume":"34","author":"Shiba","year":"2014","journal-title":"Rheumatol Int"},{"key":"R64-20261001","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1097\/RHU.0000000000001282","article-title":"Thionamide-induced myositis: report of a case and systematic review of literature","volume":"27","author":"Thomas","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"R65-20261001","doi-asserted-by":"crossref","first-page":"736036","DOI":"10.3389\/fimmu.2021.736036","article-title":"Proton pump inhibitors increase the risk of autoimmune diseases: a nationwide cohort study","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"R66-20261001","first-page":"1204","article-title":"Infections preceding diagnosis associated with myositis phenotypes in a national patient registry (MYOVISION)","volume":"43","author":"Ohnishi","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"R67-20261001","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/annrheumdis-2017-211174","article-title":"Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study","volume":"76","author":"Svensson","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R68-20261001","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","article-title":"Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset","volume":"47","author":"Manlhiot","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R69-20261001","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/annrheumdis-2020-217522","article-title":"Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis","volume":"79","author":"Megremis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R70-20261001","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol Int"},{"key":"R71-20261001","doi-asserted-by":"crossref","first-page":"105136","DOI":"10.1016\/j.ebiom.2024.105136","article-title":"MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)","volume":"104","author":"David","year":"2024","journal-title":"EBioMedicine"},{"key":"R72-20261001","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1093\/rheumatology\/kead149","article-title":"Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study","volume":"62","author":"Ali","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"R73-20261001","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI113098","article-title":"Coxsackievirus B 1-induced polymyositis. Lack of disease expression in nu\/nu mice","volume":"80","author":"Ytterberg","year":"1987","journal-title":"J Clin Invest"},{"key":"R74-20261001","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0022-2143(96)90029-3","article-title":"Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes","volume":"128","author":"Tam","year":"1996","journal-title":"J Lab Clin Med"},{"key":"R75-20261001","doi-asserted-by":"crossref","first-page":"10113","DOI":"10.1128\/JVI.73.12.10113-10121.1999","article-title":"Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: Viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution","volume":"73","author":"Tam","year":"1999","journal-title":"J Virol"},{"key":"R76-20261001","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/art.1780291109","article-title":"Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis","volume":"29","author":"Christensen","year":"1986","journal-title":"Arthritis Rheum"},{"key":"R77-20261001","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/art.1780381019","article-title":"Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis","volume":"38","author":"Pachman","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R78-20261001","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0140-6736(92)91134-T","article-title":"Viruses in the idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle","volume":"339","author":"Leff","year":"1992","journal-title":"Lancet"},{"key":"R79-20261001","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1212\/WNL.0000000000002291","article-title":"Hepatitis C virus infection in inclusion body myositis: a case-control study","volume":"86","author":"Uruha","year":"2016","journal-title":"Neurology"},{"key":"R80-20261001","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1586\/1744666X.2014.966690","article-title":"Inflammatory manifestations of HTLV-1 and their therapeutic options","volume":"10","author":"Martin","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"R81-20261001","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/mus.880151109","article-title":"Flavivirus induces MHC antigen on human myoblasts: a model of autoimmune myositis?","volume":"15","author":"Bao","year":"1992","journal-title":"Muscle Nerve"},{"key":"R82-20261001","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/ana.410290505","article-title":"Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis","volume":"29","author":"Illa","year":"1991","journal-title":"Ann Neurol"},{"key":"R83-20261001","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41598-025-33939-y","article-title":"Multikingdom gut microbiota characterization in Chinese patients with idiopathic inflammatory myopathies","volume":"16","author":"Liu","year":"2026","journal-title":"Sci Rep"},{"key":"R84-20261001","doi-asserted-by":"crossref","first-page":"1243512","DOI":"10.3389\/fcimb.2023.1243512","article-title":"Gut microbiota dysbiosis characterized by abnormal elevation of Lactobacillus in patients with immune-mediated necrotizing myopathy","volume":"13","author":"Liang","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R85-20261001","doi-asserted-by":"crossref","first-page":"1321315","DOI":"10.3389\/fcimb.2023.1321315","article-title":"Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease","volume":"13","author":"Quintero-Puerta","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R86-20261001","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/2211-5463.13334","volume":"12","author":"Lou","year":"2022","journal-title":"FEBS Open Bio"},{"key":"R87-20261001","doi-asserted-by":"crossref","first-page":"16158","DOI":"10.1038\/s41598-024-60225-0","article-title":"Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis","volume":"14","author":"Koester","year":"2024","journal-title":"Sci Rep"},{"key":"R88-20261001","first-page":"186","article-title":"The MicroIBioM study: the gut microbiome in inclusion body myositis","volume":"44","author":"Winkler","year":"2026","journal-title":"Clin Exp Rheumatol"},{"key":"R89-20261001","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaut.2012.05.002","article-title":"Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop","volume":"39","author":"Miller","year":"2012","journal-title":"J Autoimmun"},{"key":"R90-20261001","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/s41598-020-64865-w","article-title":"The early local and systemic Type I interferon responses to ultraviolet B light exposure are cGAS dependent","volume":"10","author":"Skopelja-Gardner","year":"2020","journal-title":"Sci Rep"},{"key":"R91-20261001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/BOR.0000000000000318","article-title":"Environmental exposures and the development of systemic lupus erythematosus","volume":"28","author":"Barbhaiya","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R92-20261001","first-page":"431","article-title":"SLE risk: The role of environmental factors","volume":"24","author":"Liu","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"R93-20261001","doi-asserted-by":"crossref","first-page":"1384606","DOI":"10.3389\/fimmu.2024.1384606","article-title":"Interferon alpha promotes caspase-8 dependent ultraviolet light-mediated keratinocyte apoptosis via interferon regulatory factor 1","volume":"15","author":"Loftus","year":"2024","journal-title":"Front Immunol"},{"key":"R94-20261001","first-page":"276","article-title":"Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoimmunity","volume":"30","author":"Fraser","year":"2003","journal-title":"J Rheumatol"},{"key":"R95-20261001","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/ard.2003.012740","article-title":"Seasonal variation of disease activity of systemic lupus erythematosus in Finland: a 1\u200ayear follow up study","volume":"63","author":"Hasan","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R96-20261001","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3899\/jrheum.111196","article-title":"Seasonal variation in the activity of systemic lupus erythematosus","volume":"39","author":"Duarte-Garc\u00eda","year":"2012","journal-title":"J Rheumatol"},{"key":"R97-20261001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/1744666X.2018.1473035","article-title":"Cigarette smoking and the pathogenesis of systemic lupus erythematosus","volume":"14","author":"Speyer","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"R98-20261001","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/art.42929","article-title":"Air pollution, genetic susceptibility, and risk of incident systemic lupus erythematosus: a prospective cohort study","volume":"76","author":"Xing","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R99-20261001","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1289\/ehp.1002123","article-title":"Associations between ambient fine particulate levels and disease activity in patients with systemic lupus erythematosus (SLE)","volume":"119","author":"Bernatsky","year":"2011","journal-title":"Environ Health Perspect"},{"key":"R100-20261001","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/09612033241232054","article-title":"Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series","volume":"33","author":"Cahuapaza-Gutierrez","year":"2024","journal-title":"Lupus"},{"key":"R101-20261001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fimmu.2016.00103","article-title":"Early life factors associated with adult-onset systemic lupus erythematosus in women","volume":"7","author":"Parks","year":"2016","journal-title":"Front Immunol"},{"key":"R102-20261001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acr.25497","article-title":"Environmental risk factors for systemic lupus erythematosus through the lens of social determinants of health","volume":"77","author":"Kim","year":"2025","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R103-20261001","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0961203318778368","article-title":"Less than 7\u200ah of sleep per night is associated with transitioning to systemic lupus erythematosus","volume":"27","author":"Young","year":"2018","journal-title":"Lupus"},{"key":"R104-20261001","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/0961203313511680","article-title":"Pesticides, chemical and industrial exposures in relation to systemic lupus erythematosus","volume":"23","author":"Parks","year":"2014","journal-title":"Lupus"},{"key":"R105-20261001","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","volume":"24","author":"James","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R106-20261001","doi-asserted-by":"crossref","first-page":"100163","DOI":"10.1016\/j.jtauto.2022.100163","article-title":"Association between Toxoplasma gondii and systemic lupus erythematosus: a systematic review and meta-analysis","volume":"5","author":"Bassett","year":"2022","journal-title":"J Transl Autoimmun"},{"key":"R107-20261001","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12940-023-01019-1","article-title":"Association of perfluoroalkyl and polyfluoroalkyl substances (PFASs) exposures and the risk of systemic lupus erythematosus: a case-control study in China","volume":"22","author":"He","year":"2023","journal-title":"Environ Health"},{"key":"R108-20261001","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/art.24398","article-title":"Combined oral contraceptive use and the risk of systemic lupus erythematosus","volume":"61","author":"Bernier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R109-20261001","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00081-19","article-title":"Low-level parasite persistence drives vasculitis and myositis in skeletal muscle of mice chronically infected with Trypanosoma cruzi","volume":"87","author":"Weaver","year":"2019","journal-title":"Infect Immun"},{"key":"R110-20261001","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.3390\/ijms150814269","article-title":"Expert panel workshop consensus statement on the role of the environment in the development of autoimmune disease","volume":"15","author":"Parks","year":"2014","journal-title":"Int J Mol Sci"},{"key":"R111-20261001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2025.08.003","article-title":"Overview of climate change, pollution, and sustainability in the rheumatic and autoimmune diseases","volume":"52","author":"Miller","year":"2026","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:02:29Z","timestamp":1790834549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":111,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001184","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}